Cosegregation of a factor VIII microsatellite marker with mild hemophilia A in golden retriever dogs

Journal of Veterinary Internal Medicine

Volumn 19, Issue 2, 2005, Pages 205-210

  Brooks, Marjory B ^a,c   Barnas, Jennifer L ^b   Fremont, Jacqueline ^b   Ray, Jharna ^b  

^a College of Veterinary Medicine ^*  (United States)

^b Cornell University ^*  (United States)

^c Animal Health Diagnostic Center   (United States)

Author keywords

Canine hereditary disease; Carrier analysis; Factor VIII deficiency; Polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ALLELE; ARTICLE; BLEEDING; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOG; FEMALE; GENOTYPE; HEMOPHILIA A; HETEROZYGOTE DETECTION; HOMOZYGOSITY; MALE; MICROSATELLITE MARKER; NONHUMAN; PEDIGREE; PHENOTYPE; SEX ROLE;

ANIMALS; DOG DISEASES; DOGS; FACTOR VIII; GENOTYPE; HEMOPHILIA A; MICROSATELLITE REPEATS; PEDIGREE;

CANIS FAMILIARIS;

EID: 16244385590     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19<205:COAFVM>2.0.CO;2     Document Type: Article

References (46)

1. Thompson AR. Molecular biology of the hemophilias. In: Coller BS, ed. Progress in Hemostasis and Thrombosis. Philadelphia, PA: WB Saunders: 1991:175-214.
2. Goodeve AC. Laboratory methods for the genetic diagnosis of bleeding disorders. Clin Lab Haematol 1998;20:3-19.
3. Hoyer LW. Hemophilia A. N Engl J Med 1994;330:38-47.
4. Peake IR, Lillicrap DP, Boulyjenkov V, et al. Report of a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis. Blood Coagul Fibrinolysis 1993;4:313-344.
5. Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol 1998;59:288-294.
6. MRC Haemostasis Research Group. The haemophilia A mutation, structure, test, and resource site. Nucleic Acids Res 1996;24:100-102.
7. Association of Hemophilia Clinic Directors of Canada. Hemophilia and von Willebrand's disease: Management. Can Med Assoc J 1995;153:147-157.
8. Linden JV, Kolakoski MH, Lima JE, et al. Factor concentrate usage in persons with hemophilia in New York State. Transfusion 2003;43:470-475.
9. McGinniss MJ, Kazazian HH Jr, Hoyer LW, et al. Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A. Genomics 1993;15:392-398.
10. Poon MC, Hoar DI, Low S, et al. Hemophilia A carrier detection by restriction fragment length polymorphism analysis and discriminant analysis based on ELISA of factor VIII and vWF. J Lab Clin Med 1992;119:751-762.
11. Bowen DJ. Haemophilia A and haemophilia B: Molecular insights. J Clin Pathol Mol Pathol 2002;55:127-144.
12. Cutler JA, Mitchell MJ, Smith IC, et al. The identification and classification of 41 novel muations in the FVIII gene. Hum Mutat 2002;19:274-278.
13. Millar DS, Kakkar VV, Cooper DN. Screening for inversions in the factor VIII gene causing severe hemophilia A. Blood Coagul Fibrinolysis 1994;5:239-242.
14. Graham JB, Rizza CR, Chediak J, et al. Carrier detection in hemophilia A: A cooperative international study: I. The carrier phenotype. Blood 1986;67:1554-1559.
15. Xuefeng W, Yuanfang L, Zhiguang L, et al. Carrier detection and prenatal diagnosis of hemophilia A. Clin Chem Lab Med 2001;39:1204-1208.
16. Tagariello G, Belvini D, Salviato R, et al. Experience of a single Italian center in genetic counseling for hemophilia: From linkage analysis to molecular diagnosis. Haematologica 2000;85:525-529.
17. Srinivasan A, Mukhopadhyay S, Karim Z, et al. Factor VIII gene polymorphisms in north Indian population: A consensus algorithm for carrier analysis of hemophilia A. Clin Chim Acta 2002;325:177-181.
18. Liu J, Liu Q, Liang Y, et al. PCR assay for the inversion causing severe hemophilia A and its application. Chin Med J 1999;112:419-423.
19. Dodds WJ, Moynihan AC, Fisher TM, et al. The frequencies of inherited blood and eye diseases as determined by genetic screening programs. J Am Anim Hosp Assoc 1981;17:697-704.
20. Brooks MB. A review of canine inherited bleeding disorders: Biochemical and molecular strategies for disease characterization and carrier detection. J Hered 1999;90:112-118.
21. Joseph SA, Brooks MB, Coccari PJ, et al. Hemophilia A in a German Shorthaired Pointer: Clinical presentation and diagnosis. J Am Anim Hosp Assoc 1996;32:25-28.
22. Carr AP, Panciera DL. von Willebrand's disease and other hereditary coagulopathies. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders Co; 2000:434-437.
23. Fogh JM. A study of hemophilia A in German Shepherd Dogs in Denmark. Vet Clin North Am 1988;18:245-254.
24. Parry BW, Howard MA, Mansell PD, et al. Hemophilia A in German Shepherd Dogs. Aust Vet J 1988;65:276-279.
25. Tennant B. The problem of inherited diseases. 3: Haemophilia in the German Shepherd. J Small Anim Pract 1996;37:405-406.
26. Hein H. Haemophilia A in German Shepherd Dogs. Vet Rec 1986;118:619.
27. Mischke R, Rivera Ramirez PA, Deniz A, et al. Hemophilia A in the dog: Symptoms, blood coagulation analysis and treatment [in German]. Berl Munch Tierarztl Wochenschr 1996;109:279-287.
28. Brooks MB, Gu W, Barnas JL, et al. A line 1 insertion in the factor IX gene segregates with mild hemophila B in dogs. Mamm Genome 2003;14:788-795.
29. Mellersh CS, Langston AA, Acland GM, et al. A linkage map of the canine genome. Genomics 1997;46:326-336.
30. Stokol T, Brooks MB, Erb HN. Effect of citrate concentration on coagulation test results in dogs. J Am Vet Med Assoc 2000;217:1672-1677.
31. Hough C, Kamisue S, Cameron C, et al. Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: Similarities with the intron 22 inversion in human hemophilia. Thromb Haemost 2002;87:659-665.
32. Benson RE, Catalfamo JL, Brooks MB, et al. A sensitive immunoassay for von Willebrand factor. J Immunoassay 1991;12:371-390.
33. Kawaski E. Sample preparation from blood, cells, and other fluids. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications. San Diego, CA: Academic Press, Harcourt Brace Jovanovich; 1990:146-152.
34. Colton T. Inference on proportions. In: Statistics in Medicine, 1st ed. Boston, MA: Little, Brown and Co; 1974:151-188.
35. O'Brien SR, Sellers TS, Meyer DJ. Artifactual prolongation of the activated partial thromboplastin time associated with hemoconcentration in dogs. J Vet Intern Med 1995;9:169-170.
36. Humphries JE, Acker MN, Schnell DE, et al. Artifactual prolongation of the activated partial thromboplastin time mimicking a coagulopathy. A lesson relearned. Am J Clin Pathol 1993;100:108-110.
37. Ray MJ. An artefact related to the ratio of sample volume to the blood collection vial size which effects the APTTs of specimens taken to monitor heparin therapy. Thromb Haemost 1991;66:387-388.
38. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37:220-227.
39. Bigge LA, Brown DJ, Penninck DG. Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993-1996). J Am Anim Hosp Assoc 2001;37:228-233.
40. Kirby R, Rudloff E. Acquired coagulopathy VI: Disseminated intravascular coagulation. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott, Williams & Williams; 2000:581-587.
41. Mischke R. Activated partial thromboplastin time as a screening test of minor or moderate coagulation factor deficiencies for canine plasma: Sensitivity of different commercial reagents. J Vet Diagn Invest 2000;12:433-437.
42. Sanfelippo MJ, McMahon EJ. Are the new reagents really more sensitive? Am J Clin Pathol 2000;113:742-743; author reply 744-745.
43. Veillon DM, Garcia A, Tubbs KF, et al. Problems associated with increased sensitivity. Am J Clin Pathol 2000;113:743-745.
44. Antonarakis SE, Waber PF, Kittur SD, et al. Hemophilia A. Detection of molecular defects and of carriers by DNA analysis. N Engl J Med 1985;313:842-848.
45. Lalloz MA, McVey JH, Pattinson JK, et al. Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the fVIII gene. Lancet 1991;338:207-211.
46. Haddad AP, Sparrow RL. Instability in the ATCT variable number tandem repeat locus VWF:VNTR I in intron 40 of the von Willebrand factor gene. Br J Haematol 1997;98:662-664.